Canterbury DHB


Chronic Lymphocytic Leukaemia

Autografting is currently not standard treatment for CLL. Allografting is occasionally considered usually as a RIC SCT following Fludarabine/TBI conditioning. Standard allografts in CLL have a high treatment related mortality.

About this Canterbury DHB document (9184):

Document Owner:

Andrew Butler (see Who's Who)

Last Reviewed:

December 2016

Next Review:

December 2018


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 9184